Presentations Image EN Corporate / 29.08.2024 IBA Half Year 2024 Results Presentation Read more IBA Half Year 2024 Results Presentation Financial results for 2023 Annual reports - all years Annual report 2023 IFRS consolidated results June 30 - all years Financial calendar & events Financial results press releases 2023 Financial results press releases- all years Our latest press releases View all press releases Subscribe to corporate press releases Subscribe to IBA Group regulated press releases distribution list Professional email First name Last name Phone number Company I am an Investor Banker Media representative Financial analyst By submitting this form, I acknowledge that my information will be processed in accordance with IBA’s Privacy Policy. × Press releases Image EN FR Corporate / 11.09.2024 IBA’s joint venture PanTera secures EUR 93 million in oversubscribed Series A round to accelerate global actinium-225 production Read more IBA’s joint venture PanTera secures EUR 93 million in oversubscribed Series A round to accelerate global actinium-225 production Press releases Image EN FR Corporate / 29.08.2024 IBA Reports Half Year 2024 Results Read more IBA Reports Half Year 2024 Results Press releases Image FR EN Proton Therapy / 27.08.2024 IBA secures deal with the University of Pennsylvania Health System for two Proteus®ONE proton therapy solutions Read more IBA secures deal with the University of Pennsylvania Health System for two Proteus®ONE proton therapy solutions Business analyst coverage Laura Roba Degroof Petercam Contact Michiel Declerq KBC Securities Contact David Vagman ING Contact Mathias Maenhaut Kepler Cheuvreux Contact Contact us A specific question ? We will be glad to help ! Your investor relations contact Soumya Chandramouli - Chief Financial Officier Tel: +32 10 47 58 90 Send us an email
Presentations Image EN Corporate / 29.08.2024 IBA Half Year 2024 Results Presentation Read more IBA Half Year 2024 Results Presentation
Press releases Image EN FR Corporate / 11.09.2024 IBA’s joint venture PanTera secures EUR 93 million in oversubscribed Series A round to accelerate global actinium-225 production Read more IBA’s joint venture PanTera secures EUR 93 million in oversubscribed Series A round to accelerate global actinium-225 production
Press releases Image EN FR Corporate / 29.08.2024 IBA Reports Half Year 2024 Results Read more IBA Reports Half Year 2024 Results
Press releases Image FR EN Proton Therapy / 27.08.2024 IBA secures deal with the University of Pennsylvania Health System for two Proteus®ONE proton therapy solutions Read more IBA secures deal with the University of Pennsylvania Health System for two Proteus®ONE proton therapy solutions
